Symptom prevalence and control during cancer patients' last days of life. The lack of control of physical suffering among cancer patients in the last days or hours of life is a common medical problem but it is rarely discussed in... V, Ventafridda,C, Ripamonti,FD Conno,... - 《Journal...
The authors examined the place of death preference of forty-one terminally ill cancer patients and eighteen of their informal caregivers in the Morecambe Bay area, northwest of England. Thirteen factors were identified as shaping the place of death preference of patients and caregivers. They are ...
Assistance to Patients with Terminal Cancer in the Last 30 Days Prior to Death: Differences in the Care of the Usual Health Care Units and a Palliative Car... The elaboration of the care plan for patients with terminal cancer must be based on a careful evaluation of clinical, bioethical and...
I once had a friend that was diagnosed with terminal cancer and the news that he might only live up to six months was a great shock to him his family and his friends.However in spite of the serious illness he was initially(开始) determined to look into all available treatments that might...
...terminalcancer. 晚期癌症 柯林斯高阶英语词典 ...his illness wasterminal. 他的病没治了。 柯林斯高阶英语词典 They have started a hospice forterminalpatients. 他们为身患绝症的病人开办了一个安养所。 柯林斯高阶英语词典 Plans are underway for a fifthterminalat Heathrow airport. ...
Terminally Ill Cancer Patients and End-of-Life Legal Concerns Because cancer is often an aggressive andterminal illness, patients may face end-of-life concerns and considerations that are not necessarily presented to patients being treated for curable diseases. For example, medical advanced directives ...
Currently, although the clinical application of farnesyltransferase inhibitors can extend patients’ lives, it does not completely prevent the accumulation of progerin, accompanied by adverse reactions such as diarrhea and vomiting, and these factors limit the effect of farnesyltransferase inhibitors as a ...
Patients with cancer or in terminal stages of illness often have unbearable pain.88 Parlow and colleagues evaluated the use of N2O/O2 in a small number of patients. They concluded that nitrous oxide was beneficial and deserved to be considered for patients in pain.89 3. In such cases, the ...
The first is sudden death5; the second is a period of steep decline, typically related to cancer or other terminal illness that can last months to years. The third is characterized by chronic conditions such as heart failure and emphysema and can last months to years with...
Pharmacological inhibition of driver protein kinases by small-molecule inhibitors is one of the main therapeutic strategies to treat cancer patients. We solved the crystal structure of c-Src KD in complex with Ponatinib (Fig. 6a, b), a type-II tyrosine kinase inhibitor used for the treatment of...